Related Experiment Video
Updated: May 2, 2026

05:18
Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
2.0K
Brachial neuritis following a corticosteroid injection.
Matthew Robinson1, Mark Fulcher
1Unisports Sports Medicine, Auckland, New Zealand.
BMJ Case Reports
|March 6, 2014
Summary
Subacromial corticosteroid injections may trigger brachial neuritis, leading to persistent anterior interosseous neuropathy. This case highlights the need to consider injections as a potential cause of brachial plexus injuries.
Area of Science:
- Neurology
- Orthopedic Surgery
- Pain Management
Background:
- Brachial neuritis is an idiopathic condition affecting the brachial plexus.
- Subacromial corticosteroid injections are commonly used for shoulder pain.
Observation:
- A patient developed anterior interosseous neuropathy after a subacromial corticosteroid injection.
- No other trigger for the neuropathy was identified.
Findings:
- The anterior interosseous nerve, part of the brachial plexus, was affected.
- The neuropathy showed no recovery after two years.
Implications:
- Corticosteroid injections should be considered a potential cause of brachial neuritis.
- Brachial neuritis must be included in the differential diagnosis for severe arm pain and weakness.
- The anterior interosseous nerve is implicated in a significant portion of brachial neuritis cases.
Related Concept Videos
Spinal Nerves: Plexus I
3.3K
Nerve plexuses are networks of interlacing nerves that serve as communication hubs to distribute and organize nerve action across various body regions. The nerve plexuses are organized into the cervical plexus located in the neck region, brachial plexus in the shoulder area, lumbar plexus found in the lower back, sacral plexus situated in the pelvis, and coccygeal plexus located in the coccygeal region.
The Cervical Plexus
The cervical plexus, formed by the anterior rami of the first four...
The Cervical Plexus
The cervical plexus, formed by the anterior rami of the first four...
3.3K
Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Myasthenia Gravis: Diagnostic Tests
3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Encephalitis l: Introduction
15
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
15
Drug Delivery: Parenteral Route
2.8K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
2.8K

